Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Pavlik Harness for Developmental Dysplasia of the Hip (DDH)
Treatment for Congenital musculoskeletal and limb anomalies
Typical Dosage: Continuous wear of harness, adjusted weekly
Effectiveness
98%
Safety Score
88%
Clinical Trials
200
Participants
30K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
88
DangerousModerateSafe
Treatment Details
Dosage Range
Continuous wear of harness, adjusted weekly
Time to Effect
6-12 weeks for hip stabilization
Treatment Duration
6-12 weeks full-time, then potentially part-time for another 4-6 weeks
Evidence Quality
HIGHConfidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$800
Side Effect Mgmt:$50
Total Annual:$850
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$15,000/QALY
QALYs Gained
0.9
Outcome-Based Costs
Cost per Responder
$867.35
Cost per Remission
$894.74
Comparison vs Surgical Reduction for DDH
Cost Difference
$-19,150/year
Less expensive
QALY Difference
+0.30 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Pavlik Harness for Developmental Dysplasia of the Hip (DDH) Outcomes
for Congenital musculoskeletal and limb anomalies
Efficacy Outcomes
Overall Effectiveness
+98%
Response Rate
+98%
Remission Rate
+95%
Common Side Effects
Skin irritation
+10%
Femoral nerve palsy (temporary)
+1%
Avascular necrosis of femoral head (rare)
+0.5%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov